1 Gu XF, Raynaud F, Evain-Brion D. Increased chemotactic and mitogenic response of psoriatic fibroblasts to platelet-derived growth factor. J Invest Dermatol, 1988,91:599-602.
2 Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti PCNA/cyclin monoclonal antibodies in fixed, embedded tissues:comparison with flow
cytometric analysis. Am J Pathol, 1988,134:733-739.
3 Krane JF, Murphy DP, Gottieb AB, et al. Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis. J Invest Dermatol,1991,96:983-986.
4 Eming SA, Lee J, Snow RG, et al. Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice implications for the use of genetically modified keratinocytes to modulate dermal regeneration.J Invest Dermatol, 1995, 105:756-763.
5 Ross R. Peptide regulatory factors:platelet-derived growth factor. Lancet, 1989,Ⅰ (8648):1179-1182. |
